Pod 204 - Understanding biosynthesis in the cannabis sector

<p>On this episode of BofC Live, we connect with Dr. Mather Carscallen, the CEO and CTO of Algae-C – a plant biosynthesis company using algae to create plant-derived active pharmaceutical ingredients (APIs) – including cannabinoids. Carscallen describes the process of using algae for biosynthesis and the value it has to the cannabis sector – including cost, consistency and environmental impact.</p><p>BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector.</p><p>Learn more about <a href="https://bofc.me/algaec" target="_blank">Algae-C</a>.</p>